BiomX Inc. Files Q1 2025 Quarterly Report
Ticker: PHGE · Form: 10-Q · Filed: May 15, 2025 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biotechnology
TL;DR
BiomX Inc. filed its Q1 2025 10-Q. All systems go.
AI Summary
BiomX Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Chardan Healthcare Acquisition Corp., is focused on biological products. Its business address is located at 22 Einstein St., Floor 4, Ness Ziona, Israel.
Why It Matters
This filing provides investors and stakeholders with an update on BiomX Inc.'s financial and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Players & Entities
- BiomX Inc. (company) — Registrant
- Chardan Healthcare Acquisition Corp. (company) — Former company name
- March 31, 2025 (date) — End of reporting period
- 22 Einstein St., Floor 4, Ness Ziona, Israel (location) — Business address
FAQ
What is the primary business of BiomX Inc.?
BiomX Inc. is primarily involved in the business of biological products, specifically excluding diagnostic substances, as indicated by its SIC code [2836].
When was BiomX Inc. formerly known as Chardan Healthcare Acquisition Corp.?
BiomX Inc. was formerly known as Chardan Healthcare Acquisition Corp. until April 30, 2018, when its name was changed.
What is the SEC file number for BiomX Inc.?
The SEC file number for BiomX Inc. is 001-38762.
What is the fiscal year end for BiomX Inc.?
BiomX Inc.'s fiscal year ends on December 31.
Where is BiomX Inc. located?
BiomX Inc.'s business and mailing address is 22 Einstein St., Floor 4, Ness Ziona, Israel, 7414003.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding BiomX Inc. (PHGE).